Loading...
Bioequivalence of a Metformin/Linagliptin Fixed-Dose Combination Tablet Compared With Coadministered Single Extended-Release Agents in Healthy Adult Subjects
Conclusion: The metformin/linagliptin 1000 mg/5 mg FDC tablet is bioequivalent to coadministration of individual XR tablets in healthy Korean adults under fasting conditions. The FDC tablet was well tolerated, indicating that it is a safe and effective option that could improve medication adherence...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wiley
2025-01-01
|
| Series: | International Journal of Clinical Practice |
| Online Access: | http://dx.doi.org/10.1155/ijcp/7111508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|